Modulation and pre-amplification of PAR1 signaling by ADP acting via the P2Y12 receptor during platelet subpopulation formation

被引:26
|
作者
Shakhidzhanov, S. S. [1 ]
Shaturny, Vi [1 ]
Panteleev, Ma. [1 ,2 ,3 ,4 ]
Sveshnikoya, A. N. [1 ,2 ,3 ]
机构
[1] Moscow MV Lomonosov State Univ, Fac Phys, Moscow 119991, Russia
[2] Fed Res & Clin Ctr Pediat Hematol Oncol & Immunol, Moscow 117198, Russia
[3] Russian Acad Sci, Ctr Theoret Problems Physicochem Pharmacol, Moscow 119991, Russia
[4] Moscow Inst Phys & Technol, Fac Biol & Med Phys, Dolgoprudnyi 141700, Russia
来源
基金
俄罗斯科学基金会;
关键词
Calcium signaling; Differential equations; Adenylyl cyclase; Cyclic AMP; Phospholipase C; Mitochondria; DEPENDENT PROTEIN-KINASE; PROCOAGULANT ACTIVITY; SYSTEMS-APPROACH; PHOSPHATIDYLSERINE EXPOSURE; MITOCHONDRIAL CALCIUM; GRANULE SECRETION; ADENYLYL-CYCLASE; SOLUTE TRANSPORT; BINDING-SITES; ACTIVATION;
D O I
10.1016/j.bbagen.2015.09.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Two major soluble blood platelet activators are thrombin and ADP. Of these two, only thrombin can induce mitochondrial collapse and programmed cell death leading to phosphatidylserine (PS) exposure required for blood clotting reactions acceleration. Thrombin can also greatly potentiate collagen-induced PS exposure. However, ADP acting through the P2Y12 receptor was shown to increase the PS-exposing (PS) platelets fraction produced by thrombin or thrombin-plus-collagen via an unknown mechanism. Methods: We developed a comprehensive multicompartmental computational model of platelet PAR(1)-and-P2Y12 calcium signal transduction that included cytoplasmic signaling, dense tubular system and mitochondria. To test model predictions, flow cytometry experiments with washed, annexin V-labeled platelets were performed. Results: Stimulation of thrombin receptor PAR(1) in the model induced cytoplasmic calcium oscillations, calcium uptake by mitochondria, opening of the permeability transition pore and collapse of the mitochondrial membrane potential. ADP stimulation of P2Y12 led to cAMP decrease that, in turn, caused changes in phospholipase C phosphorylation by protein kinase A, increase in cytoplasmic calcium level and, consequently, PS + platelet formation. ADP addition before stimulation of PARi produced much greater increase of the PS + fraction because cAMP concentration had time to go down prior to calcium oscillations; this prediction was also tested and confirmed experimentally. Conclusion: These results suggest a mechanism of ADP-dependent PS exposure regulation and show a likely mode of action that could be important for the PS exposure regulation in thrombi, where ADP is released before thrombin formation. (C) 2015 Published by Elsevier B.V.
引用
收藏
页码:2518 / 2529
页数:12
相关论文
共 50 条
  • [31] Platelet reactivity in response to P2Y12, thromboxane, and PAR1 agonists among patients with acute ischemic stroke and large vessel occlusion
    Bender, Matthew T.
    Bhalla, Tarun
    Mattingly, Thomas
    Cameron, Scott J.
    Morrell, Craig
    VASCULAR MEDICINE, 2020, 25 (03) : NP30 - NP30
  • [32] Synergistic action between inhibition of P2Y12/P2Y1 and P2Y12/thrombin in ADP- and thrombin-induced human platelet activation
    Nylander, S
    Mattsson, C
    Ramström, S
    Lindahl, TL
    BRITISH JOURNAL OF PHARMACOLOGY, 2004, 142 (08) : 1325 - 1331
  • [33] The Signaling Pathway of the ADP Receptor P2Y12 in the Immune System: Recent Discoveries and New Challenges
    Entsie, Philomena
    Kang, Ying
    Amoafo, Emmanuel Boadi
    Schoeneberg, Torsten
    Liverani, Elisabetta
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [34] Platelet P2Y12 receptor signaling in patients with diabetes mellitus: an in vitro pharmacodynamic study
    Ueno, M.
    Ferreiro, J. L.
    Dharmashankar, K.
    Capodanno, D.
    Alissa, R.
    Desai, B.
    Tomasello, S. D.
    Charlton, R. K.
    Bass, T. A.
    Angiolillo, D. J.
    EUROPEAN HEART JOURNAL, 2010, 31 : 173 - 174
  • [35] Effect of immature platelets on ADP-induced platelet reactivity after infusion of the P2Y12 receptor inhibitor cangrelor and transitioning to oral P2Y12 inhibitors
    Stratz, C.
    Nuhrenberg, T.
    Kleiner, P.
    Leggewie, S.
    Neumann, F. J.
    Hochholzer, W.
    Trenk, D.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 : S23 - S23
  • [36] The relative importance of the ADP receptors, P2Y12 and P2Y1, in thrombin-induced platelet activation
    Nylander, S
    Mattsson, C
    Ramström, S
    Lindahl, TL
    THROMBOSIS RESEARCH, 2003, 111 (1-2) : 65 - 73
  • [38] Genetic variants of platelet ADP receptor P2Y12 associated with changed platelet functional activity and development of cardiovascular diseases
    O. V. Sirotkina
    A. M. Zabotina
    O. A. Berkovich
    E. A. Bazhenova
    T. V. Vavilova
    A. L. Schwarzman
    Russian Journal of Genetics, 2009, 45 : 218 - 223
  • [39] Genetic variants of platelet ADP receptor P2Y12 associated with changed platelet functional activity and development of cardiovascular diseases
    Sirotkina, O. V.
    Zabotina, A. M.
    Berkovich, O. A.
    Bazhenova, E. A.
    Vavilova, T. V.
    Schwarzman, A. L.
    RUSSIAN JOURNAL OF GENETICS, 2009, 45 (02) : 218 - 223
  • [40] Arrestin-2 Differentially Regulates PAR4 and P2Y12 Receptor Signaling in Platelets
    Li, Dongjun
    Woulfe, Donna
    BLOOD, 2008, 112 (11) : 47 - 48